IRI’s Appel shares perspective on technology at Growth Summit
At the annual IRI Growth Summit IRI president and chief executive officer Andrew Appel Tuesday discussed his views on data and technology as the next enabler of competitive advantage.
At the annual IRI Growth Summit IRI president and chief executive officer Andrew Appel Tuesday discussed his views on data and technology as the next enabler of competitive advantage.
IRI Tuesday released findings of a new study focused on understanding the attitudes and usage motivations of legal adult cannabis users, and the projected impact of further legalization on consumer product purchase habits.
OXNARD, Calif. – CURE Pharmaceutical Tuesday announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD).
IRI‘s 2019 Growth Summit kicked off Monday at the new Gaylord Rockies Resort and Convention Center in Denver, Colo. with a record attendance of approximately 1,600 participants expected during the three-day event.
Tastykake is partnering with another Philly icon, Bassetts Ice Cream Co., to launch Cookies and Crème Mini Donuts, the first offering from Tastykake Scoop Shop, an ice cream-inspired line of sweet snacks.
WASHINGTON – Retail sales rebounded in January, the National Retail Federation said on Monday. Sales increased by 1.3% seasonally adjusted from December and by 3.6% unadjusted year-over-year. The numbers exclude automobile dealers, gasoline stations and restaurants.
Extra gum, the No. 1 selling gum brand in the U.S., announced Monday the launch of Extra Refreshers gum, the first-ever soft chew added to the brand’s portfolio. Bursting with intense freshness, the new soft chew comes in three exciting flavors: Spearmint, Polar Ice and Tropical Mist.
Kimberly-Clark Corp. announced that S. Todd Maclin and Dunia Shive have been nominated for election to its board of directors at the company’s 2019 Annual Meeting of Shareholders on May 2. Current board members John F. Bergstrom and James M. Jenness will be retiring in 2019.
Lupin announced that it has received approval for its atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer’s Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
NCAA March Madness is known for some of the most intense and deep-seated rivalries in sports history. That’s why, this March Madness, Dove Men+Care will bring college basketball’s biggest rivals together by turning the jersey into a symbol of unity.
ARLINGTON, Va. – Morning Consult Friday published an opinion piece by the National Association of Chain Drug Stores (NACDS) entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.
In its ongoing effort to help combat the nation’s opioid epidemic across the country, CVS Health announced Friday the Aetna Foundation’s $1 million grant to the Northern Shenandoah Valley Substance Abuse Coalition (the Coalition), which will help fuel the Coalition’s new Law Enforcement Overdose Int
In the midst of a very important discussion around prescription drug pricing in Washington, D.C., CVS Health sponsored an event earlier this week with CQ Roll Call titled “Empowering Patients as Partners in Health Care” to focus on the issue and the consumer experience in health care.
WASHINGTON – An impressive force of 424 advocates from all 50 states reached every Congressional office during the 2019 National Association of Chain Drug Stores (NACDS) RxIMPACT Day on Capitol Hill.
Ocean Spray values its deep-rooted legacy of powerful women in the workplace. In 1930, Elizabeth Lee founded Ocean Spray alongside two partners. At a time when the farming industry was predominantly male, Lee trusted her vision and strength to drive Ocean Spray forward.
ALEXANDRIA, Va. – A national roundtable of 17 health care quality measurement experts, patient advocates, caregivers, and patients begins work today to create a rubric for assessing the patient centeredness of quality measure development and implementation.